NMRA EPS Estimates
Neumora Therapeutics, Inc. Common Stock
$0.35
-$0.02(-4.24%)
29
Overall
60
Value
18
Tech
10
Quality
Market Cap
$66.61M
Volume
2.80M
52W Range
$0.45 - $1.85
Target Price
$6.14
NMRA EPS estimates: the consensus estimate for Neumora Therapeutics, Inc. Common Stock's current fiscal year is -$0.83 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NMRA EPS Estimates
- EPS estimate, current quarter
- $-0.19
- EPS estimate, next quarter
- $-0.16
- EPS estimate, current year
- $-0.83
- EPS estimate, next year
- $-0.69
- EPS growth, 3-year
- +32.95%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.45 |
| 2024 | $-1.53 |
| 2023 | $-3.63 |
| 2022 | $-4.81 |
| 2021 | $-10.84 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NMRA | $0.35 | -4.2% | 2.80M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neumora Therapeutics, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW